 |
|
|
| |
Cabotegravir Maintains Protective Efficacy in the Setting of Bacterial STIs: HPTN 083
|
| |
| |
CROI 2024 March 3-6 Denver
Meredith E. Clement, Brett Hanscom, Daniel Haines, Jose Bazan, Nuntisa Chotirosniramit, Sharon Mannheimer, Kenneth H. Mayer, Mayara Secco Torres da Silva, Lydia Soto-Torres, Alex R. Rinehart, James F. Rooney, Marybeth McCauley, Beatriz Grinsztejn, Raphael J. Landovitz, for HPTN 083 Study Team
|
| |
|
|
|
|
|
